CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
anti-arrhythmia agents +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000480
NCT00000480Phase 3Completed
CompareCT.gov

Multicenter Unsustained Tachycardia Trial (MUSTT)

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Jan 16, 2017

In Brief

A Phase 3 clinical trial evaluating electrophysiology, anti-arrhythmia agents, and 1 other intervention for Arrhythmia and 6 related conditions. Completed.

Detailed Summary

To determine the value of electrophysiologic (EP)-guided antiarrhythmic therapy in coronary heart disease patients at increased risk for sudden death. The study included a controlled clinical trial and a registry.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmia, Cardiovascular Diseases, Coronary Disease, Death, Sudden, Cardiac, Heart Diseases, Myocardial Ischemia, Tachycardia, Ventricular
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartSep 1, 1991
Study CompletionSep 1, 1996
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

electrophysiologyprocedure

anti-arrhythmia agentsdrug

defibrillators, implantabledevice